GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | 8/14/2026 8:25:23 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $14,519,000 | EPS -$5.31 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/14/2026 8:10:49 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $14,519,000 | EPS -$5.31 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 7/31/2026 4:19:10 PM | View | Proxy | SEC | Y 2025 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 5/13/2026 4:21:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $19,902,000 | EPS -$6.41 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/13/2026 4:07:00 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $19,902,000 | EPS -$6.41 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 3/26/2026 4:24:49 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $27,194,000 | EPS -$87.27 | ||
| Aptevo Therapeutics Inc. (APVO) | 3/26/2026 4:07:42 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $27,194,000 | EPS -$75.85 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 1/26/2026 4:06:49 PM | View | Proxy | SEC | Y 2025 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 11/6/2025 4:35:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $26,996,000 | EPS -$2.23 | ||
| Aptevo Therapeutics Inc. (APVO) | 11/6/2025 4:12:04 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $26,996,000 | EPS -$2.23 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 8/11/2025 8:23:13 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $15,624,000 | EPS -$8.40 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/11/2025 8:12:24 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $15,624,000 | EPS -$8.40 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 7/7/2025 12:13:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 5/15/2025 4:24:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $8,342,000 | EPS -$4.39 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/15/2025 4:07:08 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $8,342,000 | EPS -$4.39 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 4/25/2025 4:14:16 PM | View | Proxy | SEC | Y 2024 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 2/14/2025 9:04:07 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $15,591,000 | EPS -$87.38 | ||
| Aptevo Therapeutics Inc. (APVO) | 2/14/2025 8:52:27 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $15,591,000 | EPS -$82.37 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 11/7/2024 8:41:35 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $15,146,000 | EPS -$0.48 | ||
| Aptevo Therapeutics Inc. (APVO) | 11/7/2024 8:16:44 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $15,146,000 | EPS -$0.48 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 10/3/2024 4:46:18 PM | View | Proxy | SEC | Y 2023 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 8/8/2024 8:48:56 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $14,921,000 | EPS -$1.67 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/8/2024 8:16:26 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $14,921,000 | EPS -$1.67 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 7/15/2024 8:21:07 AM | View | Proxy | SEC | Y 2023 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 5/8/2024 8:48:42 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $17,629,000 | EPS -$368.21 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/8/2024 8:17:00 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $17,629,000 | EPS -$368.21 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 4/23/2024 4:08:00 PM | View | Proxy | SEC | Y 2023 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/5/2024 8:49:47 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $24,842,000 | EPS -$2,316.83 | ||
| Aptevo Therapeutics Inc. (APVO) | 3/5/2024 8:16:59 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $24,842,000 | EPS -$2,260.61 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 1/30/2024 8:00:34 AM | View | Proxy | SEC | Y 2023 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 1/16/2024 4:15:54 PM | View | Proxy | SEC | Y 2023 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 12/22/2023 4:16:58 PM | View | Proxy | SEC | Y 2022 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 11/14/2023 11:31:28 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $27,129,000 | EPS -$22.16 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 11/14/2023 8:46:31 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $27,129,000 | EPS -$22.16 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/10/2023 8:44:53 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $28,912,000 | EPS -$53.95 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/10/2023 8:18:57 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $28,912,000 | EPS -$53.95 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 5/11/2023 8:44:55 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $34,969,000 | EPS $17.38 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/11/2023 8:17:16 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $34,969,000 | EPS $17.38 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 4/18/2023 8:32:14 AM | View | Proxy | SEC | Y 2022 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/30/2023 8:08:43 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $3,114,000 -74.7% | Assets $34,215,000 | EPS $1.57 | |
| Aptevo Therapeutics Inc. (APVO) | 3/30/2023 7:51:31 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $0 | Assets $34,215,000 | EPS -$0.95 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 11/10/2022 8:44:33 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $31,695,000 | EPS -$1.50 | ||
| Aptevo Therapeutics Inc. (APVO) | 11/10/2022 8:17:34 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $31,695,000 | EPS -$1.50 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 8/11/2022 8:49:20 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $38,799,000 | EPS $5.58 | ||
| Aptevo Therapeutics Inc. (APVO) | 8/11/2022 8:16:48 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $38,799,000 | EPS $5.58 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 5/12/2022 8:51:31 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $3,114,000 +28.6% | Assets $45,184,000 | EPS -$1.55 | |
| Aptevo Therapeutics Inc. (APVO) | 5/12/2022 8:16:21 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $3,114,000 +28.6% | Assets $45,184,000 | EPS -$1.55 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 4/27/2022 8:34:31 AM | View | Proxy | SEC | Y 2021 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/24/2022 8:42:58 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $12,292,000 +185.3% | Assets $56,601,000 | EPS -$6.07 | |
| Aptevo Therapeutics Inc. (APVO) | 3/24/2022 8:15:52 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $3,665,000 +54.4% | Assets $56,601,000 | EPS -$1.27 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 11/12/2021 8:20:58 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $3,096,000 +111.6% | Assets $64,005,000 | EPS -$1.43 | |
| Aptevo Therapeutics Inc. (APVO) | 11/12/2021 8:17:21 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $3,096,000 +111.6% | Assets $64,005,000 | EPS -$1.43 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/12/2021 4:18:34 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $3,110,000 +557.5% | Assets $71,474,000 | EPS -$1.75 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/12/2021 4:12:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $3,110,000 +557.5% | Assets $71,474,000 | EPS -$1.75 | |
| Aptevo Therapeutics Inc. (APVO) | 5/11/2021 9:02:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $2,421,000 | Assets $68,753,000 | EPS -$1.64 | |
| Aptevo Therapeutics Inc. (APVO) | 5/11/2021 8:56:38 AM | View | Proxy | SEC | Y 2020 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 5/11/2021 8:47:06 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $2,421,000 | Assets $68,753,000 | EPS -$1.64 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 4/28/2021 4:22:55 PM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $4,309,000 -86.7% | Assets $53,547,000 | EPS -$5.23 | |
| Aptevo Therapeutics Inc. (APVO) | 3/31/2021 8:13:10 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $4,309,000 -86.7% | Assets $53,547,000 | EPS -$5.23 | |
| Aptevo Therapeutics Inc. (APVO) | 3/31/2021 8:05:41 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $2,373,000 -73.7% | Assets $53,547,000 | EPS -$1.92 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 11/10/2020 5:43:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $1,463,000 -83.8% | Assets $37,420,000 | EPS -$2.10 | |
| Aptevo Therapeutics Inc. (APVO) | 11/10/2020 4:58:52 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $1,463,000 -83.8% | Assets $37,420,000 | EPS -$2.10 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/14/2020 4:34:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $473,000 -93.6% | Assets $18,509,000 | EPS -$2.10 | |
| Aptevo Therapeutics Inc. (APVO) | 5/13/2020 4:23:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $25,244,000 | EPS $0.89 | ||
| Aptevo Therapeutics Inc. (APVO) | 4/20/2020 4:36:14 PM | View | Proxy | SEC | Y 2019 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/25/2020 3:36:51 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $32,424,000 +40.6% | Assets $53,408,000 | EPS -$13.86 | |
| Aptevo Therapeutics Inc. (APVO) | 2/11/2020 5:15:30 PM | View | Proxy | SEC | Y 2019 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 11/7/2019 1:34:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $9,011,000 +54.7% | Assets $60,556,000 | EPS -$2.15 | |
| Aptevo Therapeutics Inc. (APVO) | 11/7/2019 12:39:57 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $9,011,000 +54.7% | Assets $60,556,000 | EPS -$2.15 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/9/2019 12:35:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $7,360,000 +7.8% | Assets $66,127,000 | EPS -$4.14 | |
| Aptevo Therapeutics Inc. (APVO) | 8/9/2019 12:21:21 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $7,360,000 +7.8% | Assets $66,127,000 | EPS -$4.14 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 5/9/2019 10:01:28 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $80,841,000 | EPS -$7.64 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 5/9/2019 9:21:53 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $80,841,000 | EPS -$7.64 | ||
| Aptevo Therapeutics Inc. (APVO) | 4/26/2019 6:01:56 AM | View | Proxy | SEC | Y 2018 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 4/5/2019 5:14:18 PM | View | Proxy | SEC | Y 2018 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/18/2019 2:03:19 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $6,346,000 +125.2% | Assets $67,494,000 | EPS -$0.62 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 3/18/2019 1:53:22 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $23,067,000 +57.4% | Assets $67,494,000 | EPS -$2.39 | |
| Aptevo Therapeutics Inc. (APVO) | 1/9/2019 6:08:29 AM | View | Financials | Earnings (Prelim) | SEC | Y 2018 | Export Earnings Model | ||||
| Aptevo Therapeutics Inc. (APVO) | 11/14/2018 5:07:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $5,824,000 -5.6% | Assets $78,934,000 | EPS -$0.56 | |
| Aptevo Therapeutics Inc. (APVO) | 11/14/2018 5:00:17 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $5,824,000 -5.6% | Assets $78,934,000 | EPS -$0.56 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/9/2018 1:56:58 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $6,826,000 +93.6% | Assets $89,997,000 | EPS -$0.58 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/9/2018 10:09:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $6,826,000 +93.6% | Assets $89,997,000 | EPS -$0.58 | |
| Aptevo Therapeutics Inc. (APVO) | 5/10/2018 2:28:19 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $4,071,000 +90.1% | Assets $100,212,000 | EPS -$0.63 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 5/10/2018 9:08:04 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $4,071,000 +90.1% | Assets $100,212,000 | EPS -$0.63 | |
| Aptevo Therapeutics Inc. (APVO) | 4/20/2018 1:03:16 PM | View | Proxy | SEC | Y 2017 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/13/2018 3:47:26 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $2,818,000 -67.9% | Assets $117,007,000 | EPS -$0.46 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 3/13/2018 6:23:49 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $14,658,000 +46.8% | Assets $117,007,000 | EPS $0.33 | |
| Aptevo Therapeutics Inc. (APVO) | 11/13/2017 6:14:07 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $6,172,000 +119.2% | Assets $131,022,000 | EPS $1.75 | |
| Aptevo Therapeutics Inc. (APVO) | 11/9/2017 4:33:18 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $6,172,000 +119.2% | Assets $131,022,000 | EPS $1.75 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 8/10/2017 3:54:45 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $3,526,000 -65.4% | Assets $86,891,000 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 8/10/2017 9:13:51 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $3,526,000 -65.4% | Assets $86,891,000 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/12/2017 3:24:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $2,142,000 -73.4% | Assets $97,793,000 | ||
| Aptevo Therapeutics Inc. (APVO) | 5/12/2017 1:56:47 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $2,142,000 -73.4% | Assets $97,793,000 | Export Earnings Model | ||
| Aptevo Therapeutics Inc. (APVO) | 4/14/2017 6:07:04 AM | View | Proxy | SEC | Y 2016 | ||||||
| Aptevo Therapeutics Inc. (APVO) | 3/31/2017 10:06:15 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $9,985,000 -70.3% | Assets $91,858,000 | EPS -$5.55 | |
| Aptevo Therapeutics Inc. (APVO) | 3/31/2017 9:40:02 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $8,769,000 +5.8% | Assets $91,858,000 | EPS -$0.74 | Export Earnings Model | |
| Aptevo Therapeutics Inc. (APVO) | 11/14/2016 5:33:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $2,816,000 -57.1% | Assets $100,623,000 | EPS -$3.55 | |
| Aptevo Therapeutics Inc. (APVO) | 9/22/2016 11:49:34 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $10,193,000 +43.8% | Assets $133,470,000 | EPS -$0.63 |